About the journal
The Pharmacogenomics Journal is a journal published by Springer Nature in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Nature
- ISSN
- 1470-269X · 1473-1150
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 4,390 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.nature.com/tpj/
Index listings
- MEDLINE · 2001-01-01
- PUBMED · 2018-05-22
- Indexing
- MEDLINE · PUBMED
- APC
- 4,390 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 283 days received→accepted — computed from PubMed (n=79)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1579
Last recorded publication year
2026
h-index
110
i10-index
1160
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 95%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101083949
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Pharmacogenetics and Drug Metabolism
- Pharmacogenetics and Drug Metabolism
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Genetic Associations and Epidemiology
- Genetic Associations and Epidemiology
- Pharmacological Effects and Toxicity Studies
- Pharmacological Effects and Toxicity Studies
Show all subjects (50)
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Receptor Mechanisms and Signaling
- Receptor Mechanisms and Signaling
- Acute Lymphoblastic Leukemia research
- Computational Drug Discovery Methods
- Acute Lymphoblastic Leukemia research
- Computational Drug Discovery Methods
- Neurotransmitter Receptor Influence on Behavior
- Neurotransmitter Receptor Influence on Behavior
- Genomics and Rare Diseases
- Genomics and Rare Diseases
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Bipolar Disorder and Treatment
- Bipolar Disorder and Treatment
- Hormonal Regulation and Hypertension
- Hormonal Regulation and Hypertension
- Schizophrenia research and treatment
- Gene expression and cancer classification
- HIV/AIDS drug development and treatment
- Gene expression and cancer classification
- HIV/AIDS drug development and treatment
- Schizophrenia research and treatment
- Renal Transplantation Outcomes and Treatments
- Renal Transplantation Outcomes and Treatments
- Diabetes Treatment and Management
- Cancer therapeutics and mechanisms
- Diabetes Treatment and Management
- Cancer therapeutics and mechanisms
- Bioinformatics and Genomic Networks
- Rheumatoid Arthritis Research and Therapies
- Rheumatoid Arthritis Research and Therapies
- Bioinformatics and Genomic Networks
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Treatment of Major Depression
- Epigenetics and DNA Methylation
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ